PEN-VEE K
What it isOral penicillin V that inhibits bacterial penicillin-binding proteins; streptococcal pharyngitis and rheumatic-fever prophylaxis.
Why this oneGroup A streptococcus remains susceptible, keeping this narrow-spectrum drug first-line for strep throat.
What limits itRenal accumulation or high exposure can antagonize GABA-A and provoke seizures; allergy and absent staphylococcal coverage also matter.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Streptococcal (URI, scarlet fever, erysipelas), mild-moderate | >=12 yr | 125-250 mg q6-8h | ||
| Pneumococcal (respiratory incl. otitis media), mild-moderate | >=12 yr | 250-500 mg q6h until afebrile >=2 days | ||
| Staphylococcal skin/soft tissue, mild | >=12 yr | 250-500 mg q6-8h | ||
| Fusospirochetosis (Vincent's), oropharynx | >=12 yr | 250-500 mg q6-8h | ||
| Rheumatic fever/chorea recurrence prophylaxis | >=12 yr | 125-250 mg BID (continuing) | ||
| Bacterial endocarditis prophylaxis (dental/URI procedures) | adult | 2 g 1 h before procedure, then 1 g 6 h later | ||
| Bacterial endocarditis prophylaxis (children <60 lb) | pediatric | 1 g 1 h before, then 500 mg 6 h later |
Renal Undefined
Hepatic Undefined
Pregnancy Undefined
Lactation Undefined
NO BOXED WARNINGS
Principal riskSeizures at high dose or in renal failure; no staphylococcal cover
Cost, est. cash$5–$150/month
Generic entry1988
Legacy pregnancy categoryB
Defining liabilityAllergy, gastrointestinal effects and agent-specific renal, hepatic, hematologic or interaction risks.

Open Penicillin V in the interactive console ↗

